CohBar (NASDAQ:CWBR) Trading Up 12.5%

CohBar, Inc. (NASDAQ:CWBR)’s share price rose 12.5% during trading on Wednesday . The company traded as high as $0.90 and last traded at $0.90. Approximately 356 shares changed hands during trading, a decline of 89% from the average daily volume of 3,366 shares. The stock had previously closed at $0.80.

CohBar Stock Performance

The business has a 50 day moving average of $0.82 and a 200 day moving average of $1.08.

Institutional Investors Weigh In On CohBar

Institutional investors have recently made changes to their positions in the stock. Vanguard Group Inc. grew its stake in shares of CohBar by 88.5% during the third quarter. Vanguard Group Inc. now owns 33,293 shares of the company’s stock worth $103,000 after purchasing an additional 15,628 shares during the period. Millennium Management LLC lifted its holdings in CohBar by 241.1% during the second quarter. Millennium Management LLC now owns 208,603 shares of the company’s stock worth $40,000 after acquiring an additional 147,442 shares in the last quarter. Finally, RVW Wealth LLC bought a new position in CohBar during the fourth quarter worth about $4,029,000. 2.47% of the stock is owned by institutional investors and hedge funds.

CohBar Company Profile

CohBar, Inc, a clinical stage biotechnology company, develops mitochondria and peptides based therapeutics for the treatment of chronic and age-related diseases. It develops CB4211, a therapeutic that is in Phase 1a/1b clinical trial for the treatment of nonalcoholic steatohepatitis and obesity; and CB5138 Analogs, which is in preclinical study to treat idiopathic pulmonary fibrosis and other fibrotic diseases.